Oncology pharmacology news
ASCO 2016: Cancer drug retail prices vastly different between countries
A pilot study revealed large differences in median retail prices for 23 cancer drugs in…
Browsing: Pharmacology
ASCO 2016: Antibody drug conjugate shows early promise in small cell lung cancer
Early findings from a first-in-human clinical trial showed that antibody drug conjugate (ADC) rovalpituzumab tesirine…
ASCO 2016: Precision medicine approach may expand therapeutic options for patients
Researchers reported encouraging early results from a phase II trial that matches patients with molecular…
Surrogate endpoints poor proxy for survival in cancer drug approval process
Surrogate endpoints used to support the majority of new cancer drugs approved in the U.S.…
Study shows patients require less painkilling medication after breast-cancer surgery if they have opiate-free anesthesia
New research presented at Euroanaesthesia 2016 (London 27-30 May) shows that patients undergoing breast cancer…
ASCO 2016: Primary tumour location predicts survival in metastatic colorectal cancer
A retrospective analysis of data from a large, federally funded clinical trial finds that the…
Unfair if rare: should the PBS change the way it lists cancer drugs?
By Ian Olver, University of South Australia. The Pharmaceutical Benefits Scheme (PBS) spends over A$9 billion…
Taking aspirin could increase cancer survival by 20 percent
Patients receiving cancer treatment could increase their chance of survival by up to 20% and…
Modified flu virus can ‘resensitize’ resistant pancreatic cancer cells to chemotherapy
A common flu virus could be used to overcome patients’ resistance to certain cancer drugs…
St Vincent’s scandal
By Nial Wheate, University of Sydney – originally published on The Conversation. (ONA Editor’s note: The final section of…